ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/11 | 1,730 | 1,734 | 1,665 | 1,670 | -79 | -4.5% | 1,143,200 |
2023/09/08 | 1,748 | 1,779 | 1,729 | 1,749 | -37 | -2.1% | 816,300 |
2023/09/07 | 1,826.5 | 1,833 | 1,781 | 1,786 | -60.5 | -3.3% | 608,900 |
2023/09/06 | 1,840 | 1,871 | 1,815 | 1,846.5 | +17.5 | +1% | 599,100 |
2023/09/05 | 1,820 | 1,842.5 | 1,801.5 | 1,829 | -12 | -0.7% | 382,100 |
2023/09/04 | 1,858 | 1,859 | 1,823 | 1,841 | -17 | -0.9% | 392,800 |
2023/09/01 | 1,851 | 1,866 | 1,835 | 1,858 | -11 | -0.6% | 369,300 |
2023/08/31 | 1,859 | 1,892 | 1,859 | 1,869 | +13.5 | +0.7% | 501,600 |
2023/08/30 | 1,906 | 1,910 | 1,848 | 1,855.5 | -34 | -1.8% | 457,500 |
2023/08/29 | 1,842 | 1,899 | 1,841.5 | 1,889.5 | +55.5 | +3% | 503,600 |
2023/08/28 | 1,838.5 | 1,840.5 | 1,803 | 1,834 | +24 | +1.3% | 316,100 |
2023/08/25 | 1,770 | 1,812.5 | 1,766.5 | 1,810 | -6 | -0.3% | 347,300 |
2023/08/24 | 1,831.5 | 1,836.5 | 1,810.5 | 1,816 | -15 | -0.8% | 362,900 |
2023/08/23 | 1,758 | 1,838 | 1,757 | 1,831 | +44 | +2.5% | 484,600 |
2023/08/22 | 1,819 | 1,820 | 1,773 | 1,787 | -11.5 | -0.6% | 415,900 |
2023/08/21 | 1,742 | 1,822.5 | 1,742 | 1,798.5 | +68 | +3.9% | 693,100 |
2023/08/18 | 1,730.5 | 1,745.5 | 1,717 | 1,730.5 | -37.5 | -2.1% | 475,700 |
2023/08/17 | 1,786 | 1,800.5 | 1,755.5 | 1,768 | -36.5 | -2% | 455,400 |
2023/08/16 | 1,810 | 1,817 | 1,785.5 | 1,804.5 | -5.5 | -0.3% | 395,100 |
2023/08/15 | 1,810 | 1,833 | 1,800.5 | 1,810 | +1.5 | +0.1% | 523,400 |
2023/08/14 | 1,860 | 1,879.5 | 1,800 | 1,808.5 | -71 | -3.8% | 837,600 |
2023/08/10 | 1,780 | 1,901 | 1,774 | 1,879.5 | +105.5 | +5.9% | 1,473,600 |
2023/08/09 | 1,710 | 1,784.5 | 1,710 | 1,774 | +46 | +2.7% | 639,200 |
2023/08/08 | 1,789 | 1,796 | 1,727 | 1,728 | -45 | -2.5% | 716,700 |
2023/08/07 | 1,770 | 1,779 | 1,748.5 | 1,773 | -21 | -1.2% | 494,400 |
2023/08/04 | 1,787 | 1,806.5 | 1,773.5 | 1,794 | +9 | +0.5% | 466,700 |
2023/08/03 | 1,781 | 1,794.5 | 1,774 | 1,785 | -26.5 | -1.5% | 623,500 |
2023/08/02 | 1,809 | 1,818 | 1,797 | 1,811.5 | -17.5 | -1% | 504,600 |
2023/08/01 | 1,830 | 1,848.5 | 1,810.5 | 1,829 | +21.5 | +1.2% | 497,200 |
2023/07/31 | 1,833 | 1,833 | 1,794.5 | 1,807.5 | -15 | -0.8% | 852,100 |
2023/07/28 | 1,812 | 1,837 | 1,792 | 1,822.5 | -13 | -0.7% | 800,100 |
2023/07/27 | 1,840 | 1,849 | 1,819 | 1,835.5 | -43.5 | -2.3% | 982,700 |
2023/07/26 | 1,874 | 1,904 | 1,843 | 1,879 | +41.5 | +2.3% | 801,000 |
2023/07/25 | 1,864.5 | 1,874 | 1,807.5 | 1,837.5 | -44.5 | -2.4% | 972,400 |
2023/07/24 | 1,825 | 1,883.5 | 1,804 | 1,882 | +75 | +4.2% | 868,900 |
2023/07/21 | 1,785 | 1,819.5 | 1,778 | 1,807 | +10.5 | +0.6% | 567,800 |
2023/07/20 | 1,830 | 1,838.5 | 1,795.5 | 1,796.5 | -21 | -1.2% | 845,500 |
2023/07/19 | 1,850 | 1,860 | 1,800 | 1,817.5 | -35.5 | -1.9% | 988,600 |
2023/07/18 | 1,870 | 1,914 | 1,832 | 1,853 | -44 | -2.3% | 1,051,300 |
2023/07/14 | 1,940 | 1,949 | 1,877 | 1,897 | -14 | -0.7% | 471,300 |
2023/07/13 | 1,897.5 | 1,933 | 1,885 | 1,911 | +22 | +1.2% | 738,400 |
2023/07/12 | 1,938 | 1,951 | 1,883 | 1,889 | -42 | -2.2% | 593,200 |
2023/07/11 | 1,975 | 1,975 | 1,927 | 1,931 | -16.5 | -0.8% | 420,500 |
2023/07/10 | 1,991 | 2,004 | 1,936 | 1,947.5 | -37.5 | -1.9% | 582,900 |
2023/07/07 | 1,979 | 2,010.5 | 1,966 | 1,985 | -34 | -1.7% | 527,500 |
2023/07/06 | 2,046 | 2,063 | 2,001 | 2,019 | -41 | -2% | 584,400 |
2023/07/05 | 2,059 | 2,065 | 2,034 | 2,060 | -28 | -1.3% | 466,700 |
2023/07/04 | 2,104 | 2,104 | 2,075.5 | 2,088 | -37.5 | -1.8% | 615,400 |
2023/07/03 | 2,170 | 2,184 | 2,112 | 2,125.5 | -14.5 | -0.7% | 546,600 |
2023/06/30 | 2,129 | 2,150.5 | 2,105 | 2,140 | -26 | -1.2% | 873,200 |
401~
450
件表示中 / 2907件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム